From diet to hypothalamic dysfunction: Neuroanatomical and hormonal integration of the microbiota-hypothalamus-adipose tissue axis

Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13:221–62. https://doi.org/10.1016/S2213-8587(24)00316-4.

Article  PubMed  PubMed Central  Google Scholar 

Klöting N, Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15:277–87. https://doi.org/10.1007/s11154-014-9301-0.

Article  CAS  PubMed  Google Scholar 

Rogero MM, Calder PC. Obesity, inflammation, toll-like receptor 4 and fatty acids. Nutrients. 2018;10:1–19. https://doi.org/10.3390/nu10040432.

Article  CAS  Google Scholar 

WHO. WHO | Obesity and overweight [Internet]. Obesity and overweight. World Health Organization; 2024 [cited 2025 May 5]. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed 5 May 2025.

Zhang X, Ha S, Lau HCH, Yu J. Excess body weight: Novel insights into its roles in obesity comorbidities. 2023.

WOF. World Obesity Atlas 2024 [Internet]. London; 2024. https://s3-eu-west-1.amazonaws.com/wof-files/WOF_Obesity_Atlas_2024.pdf

Afshin A, Sur PJ, Fay KA, Cornaby L, Ferrara G, Salama JS, et al. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;393:1958–72. https://doi.org/10.1016/S0140-6736(19)30041-8.

Article  Google Scholar 

Lu W, Ou T, Song Q. others. Ultra-Processed Food Consumption Is Associated with an Increased Risk of Abdominal Obesity. 2025; https://doi.org/10.3390/foods14223955

Ferreira-Hermosillo A, Ibanez RM, Perez-Dionisio EK, Villalobos-Mata KA. Obesity as a neuroendocrine disorder. Arch Med Res. 2023. https://doi.org/10.1016/j.arcmed.2023.102896.

Article  PubMed  Google Scholar 

Yi C-X, Tschöp MH. Brain–gut–adipose-tissue communication pathways at a glance. Dis Model Mech. 2012;5:583–7. https://doi.org/10.1242/dmm.009902.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schéle E, Grahnemo L, Anesten F, Hallén A, Bäckhed F, Jansson J-O. The gut microbiota reduces leptin sensitivity and the expression of the obesity-suppressing neuropeptides Proglucagon (Gcg) and Brain-Derived Neurotrophic Factor (Bdnf) in the central nervous system. Endocrinology. 2013;154:3643–51. https://doi.org/10.1210/en.2012-2151.

Article  CAS  PubMed  Google Scholar 

Kase BE, Liese AD, Zhang J, Murphy EA, Zhao L, Steck SE. The development and evaluation of a literature-based dietary index for gut microbiota. Nutrients. 2024. https://doi.org/10.3390/nu16071045.

Article  PubMed  PubMed Central  Google Scholar 

Carrera-Bastos P, Fontes, O’Keefe. Lindeberg, Cordain. The western diet and lifestyle and diseases of civilization. Res Rep Clin Cardiol. 2011;15. https://doi.org/10.2147/RRCC.S16919.

Franks PW, Hindawi Limited. The complex interplay of genetic and lifestyle risk factors in type 2 diabetes: an overview. Scientifica (Cairo). 2012;2012:1–11. https://doi.org/10.6064/2012/482186.

Article  Google Scholar 

Fisberg M, Maximino P, Kain J, Kovalskys I, Elsevier Editora Ltda. Obesogenic environment – intervention opportunities. J Pediatr (Rio J). 2016. https://doi.org/10.1016/j.jped.2016.02.007.

Article  PubMed  Google Scholar 

Malesza IJ, Malesza M, Walkowiak J. others. High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota. 2021; https://doi.org/10.3390/cells10113164

Qin Q, Yan S, Yang Y, Chen J, Li T, Gao X, et al. A metagenome-wide association study of the gut microbiome and metabolic syndrome. Front Microbiol. 2021. https://doi.org/10.3389/fmicb.2021.682721.

Article  PubMed  PubMed Central  Google Scholar 

Zheng Y, Li T, Cui H, Song J. Dietary index for gut microbiota, metabolic syndrome, and long-term mortality: National Health and Nutrition Examination Survey, 2007–2018. Diabetol Metab Syndr. 2025;17:191. https://doi.org/10.1186/s13098-025-01761-1.

Article  PubMed  PubMed Central  Google Scholar 

Chanda D, De D. Meta-analysis reveals obesity associated gut microbial alteration patterns and reproducible contributors of functional shift. Gut Microbes. 2024. https://doi.org/10.1080/19490976.2024.2304900.

Article  PubMed  PubMed Central  Google Scholar 

Valles-Colomer M, Blanco-Míguez A, Manghi P, Asnicar F, Dubois L, Golzato D, et al. The person-to-person transmission landscape of the gut and oral microbiomes. Nature. 2023;614(7946):125–35. https://doi.org/10.1038/s41586-022-05620-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu R, Hong J, Xu X, Feng Q, Zhang D, Gu Y, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23(7):859–68. https://doi.org/10.1038/nm.4358.

Article  CAS  PubMed  Google Scholar 

Xu Z, Jiang W, Huang W, Lin Y, Chan FKL, Ng SC. Gut microbiota in patients with obesity and metabolic disorders — a systematic review. Genes & Nutrition. 2021;17(1):2. https://doi.org/10.1186/s12263-021-00703-6.

Article  Google Scholar 

Cummings JH. Short chain fatty acids in the human colon. Gut. 1981;22:763–79. https://doi.org/10.1136/gut.22.9.763.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cronin P, Joyce SA, O’Toole PW, O’Connor EM. Dietary fibre modulates the gut microbiota. Nutrients. 2021;13:1655. https://doi.org/10.3390/nu13051655.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu E, Ji X, Zhou K. Akkermansia muciniphila for the prevention of type 2 diabetes and obesity: a meta-analysis of animal studies. Nutrients. 2024;16:3440. https://doi.org/10.3390/nu16203440.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giannoudaki E, Hernandez-Santana YE. others. Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction. 2019; https://doi.org/10.1038/s41467-019-12038-1

Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, Lobley GE, et al. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol. 2006;72:3593–9. https://doi.org/10.1128/AEM.72.5.3593-3599.2006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flint HJ, Scott KP, Duncan SH, Louis P, Forano E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes. 2012;3:289–306. https://doi.org/10.4161/gmic.19897.

Article  PubMed  PubMed Central  Google Scholar 

Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ, et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe. 2015;17:662–71. https://doi.org/10.1016/j.chom.2015.03.005.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SEK, et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015;64:1744–54. https://doi.org/10.1136/gutjnl-2014-307913.

Article  CAS  PubMed  Google Scholar 

Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278:11312–9. https://doi.org/10.1074/jbc.M211609200.

Article  CAS  PubMed  Google Scholar 

Rosendo-Silva D, Viana S, Carvalho E, Reis F, Matafome P. Are gut dysbiosis, barrier disruption, and endotoxemia related to adipose tissue dysfunction in metabolic disorders? Overview of the mechanisms involved. Int Emerg Med. 2023. https://doi.org/10.1007/s11739-023-03262-3.

Article  Google Scholar 

Jiang Z, He L, Li D, Zhuo L, Chen L, Shi RQ, et al. Human gut microbial aromatic amino acid and related metabolites prevent obesity through intestinal immune control. Nat Metab. 2025;7(4):808–22. https://doi.org/10.1038/s42255-025-01246-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang K, Liao M, Zhou N, Bao L, Ma K, Zheng Z, et al. Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids. Cell Rep. 2019;26:222-235.e5. https://doi.org/10.1016/j.celrep.2018.12.028.

Comments (0)

No login
gif